Drawing for SHINE

USPTO serial 50089624

SHINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
Law office

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with SHINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tricia L. Schulz

Tricia L. Schulz Foley & Lardner LLP150 East Gilman StreetSuite 5000Madison, WI 53703

Goods and services

ClassDescriptionStatusFirst use
001Isotopes and radioisotopes for scientific or research use; Isotopes and radioisotopes for use in the manufacture of pharmaceutical preparations; Active chemical ingredients for use in the manufacture of pharmaceuticals, namely technetium-99m, lutetium-177, terbium-149, terbium-152, terbium-155, terbium-161, or actinium-225, for medical, therapeutic and diagnostic useACTIVE
005Isotopes and radioisotopes for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely non-carrier added lutetium-177; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; parent radioisotopes for the preparation of active pharmaceutical ingredients, namely molybdenum-99; radio-isotope markers for therapeutic or diagnostic use; radioactive substances for use in nuclear medicineACTIVE
009Particle accelerators and parts and accessories therefor; neutron generators other than for medical purposes and parts and accessories thereforACTIVE
010Particle accelerator for medical purposes, namely, radiological treatment of tumors; neutron generators for medical purposes, radiological imaging and treatment of tumors; nuclear medicine diagnostic imaging apparatus; radioisotope therapy apparatus and instrumentsACTIVE
039Distribution of energy; distribution and transmission of electricityACTIVE
040Generation of neutrons for use in material and equipment testing; generation of neutrons using nuclear fusion for use in material and equipment testing; nuclear fuel recycling; transmutation of used nuclear fuel; processing of hazardous materials for decontamination; used nuclear fuel treatment and disposal; production and generation of energy utilizing nuclear energy systemsACTIVE
042Medical and scientific research in the field of medical imaging and isotopes and radioisotopes for medical, therapeutic or diagnostic use; Development of isotopes and radioisotopes for medical, therapeutic or diagnostic use; research and development services in the fields of aerospace, energy systems, defense, transportation and nuclear technology; technical consulting, research, custom design and engineering services in the fields of aerospace, energy systems, defense, and nuclear technology; aerospace testing laboratory services; radiation effects testing services for scientific or medical research purposes; material testing services using neutrons; material and equipment testing services using fusion generated neutrons for scientific research purposes; laboratory research services for material and equipment testing using fusion generated neutrons; scientific research and development services in the fields of aerospace, energy systems, defense, transportation and nuclear technology; technology consulting, research, custom design and engineering services in the fields of aerospace, energy systems, defense, and nuclear technology; laboratory research services, namely, non-medical imaging services, non-medical neutron imaging servicesACTIVE
044Medical imaging services; Medical diagnostic neutron imaging servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Sep 3, 2026NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance